Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Preventive immunotherapy for seasonal allergic rhinitis in Inner Mongolia
ChiCTR2000031810Phase 4Completed
- Sponsor
- Affiliated Hospital of Inner Mongolia Medical University
- Start
- Jun 2019
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 4, open-label trial of spleen polypeptide and loratadine in seasonal allergic rhinitis (SAR) (3 arms), sponsored by Affiliated Hospital of Inner Mongolia Medical University. Primary endpoints: Routine blood, Human TH1/TH2 subclass detection and 1 more. Started Jun 2019; status: completed.
02
Drugs
spleen polypeptideloratadine
03
Conditions
seasonal allergic rhinitis (SAR)
Beyond the preview
Go deeper on ChiCTR2000031810.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000031810.